Background The fracture risk of patients with chronic obstructive pulmonary disease (COPD)
treated with inhaled corticosteroids is controversial. And some large-scale randomized …

Background The effect of inhaled corticosteroids (ICS) on fracture risk in patients with
chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study was …

BACKGROUND: There are disputes whether inhaled corticosteroids (ICS) increase the
incidence of fracture or osteoporosis among patients with COPD. The aim of this meta …

Background: Inhaled corticosteroids are used increasingly to treat people with COPD, but
the extent to which these drugs increase the risk of fracture is unclear. Aim: To quantify the …

Patients with chronic obstructive pulmonary disease (COPD) are frequently treated with
inhaled corticosteroids (ICS). However, the impact of ICS use on fracture risk remains …

Patients with chronic obstructive pulmonary disease (COPD) demonstrate a greater
osteoporosis prevalence than the general population. This osteoporosis risk may be …

Background Both inhaled corticosteroids (ICS) and long-acting β-agonists (LABA) have
been recommended for the treatment of severe/moderate chronic obstructive pulmonary …

ICS increases risk of bone demineralization and fracture in patients with COPD. It should be
generally avoided in patients with previous fractures or significant osteoporosis. If they are …

Background Oral corticosteroids (OCS) are often prescribed for chronic obstructive
pulmonary disease (COPD) exacerbations. Methods This observational, individually …

The effect of inhaled corticosteroids (ICS) on the risk of osteoporosis and fracture in patients
with chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study …